Residual Risks of Thrombotic Complications in Anticoagulated Patients with Atrial Fibrillation: A Cluster Analysis Approach from the GLORIA-AF Registry.

1 Increased adherence to clinical guidelines has enhanced the prescription rates of OACs among at-risk patients, reflecting a positive trend in clinical practice. 2 , 3 Despite judicious use of OACs, a residual risk of ischaemic stroke remains evident. 4 Real world data from a globally diverse cohort of patients with AF showed an annual incidence of stroke of 0.6%. 5 Thromboembolic risk stratification in this population is complex; risk

also in 11,005 other papers